BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,162,074 | -11.9% | 30,792 | +6.3% | 0.08% | -10.2% |
| Q2 2023 | $1,319,717 | +13.4% | 28,967 | +1.0% | 0.09% | +10.0% |
| Q1 2023 | $1,163,528 | -16.3% | 28,687 | +5.2% | 0.08% | -17.5% |
| Q4 2022 | $1,390,274 | -8.8% | 27,276 | -3.7% | 0.10% | -16.4% |
| Q3 2022 | $1,525,000 | -18.9% | 28,323 | -3.3% | 0.12% | -14.1% |
| Q2 2022 | $1,881,000 | -17.0% | 29,285 | +0.2% | 0.14% | -2.9% |
| Q1 2022 | $2,266,000 | -11.8% | 29,222 | -2.4% | 0.14% | -12.0% |
| Q4 2021 | $2,569,000 | +7.0% | 29,932 | -0.1% | 0.16% | +4.6% |
| Q3 2021 | $2,400,000 | +0.9% | 29,952 | +1.4% | 0.15% | -9.6% |
| Q2 2021 | $2,378,000 | -1.9% | 29,541 | +2.7% | 0.17% | -10.2% |
| Q1 2021 | $2,423,000 | -7.7% | 28,771 | -12.3% | 0.19% | -15.8% |
| Q4 2020 | $2,625,000 | -3.3% | 32,793 | -2.8% | 0.22% | -13.3% |
| Q3 2020 | $2,715,000 | -14.1% | 33,755 | -8.2% | 0.26% | -24.3% |
| Q2 2020 | $3,162,000 | +59.5% | 36,764 | +49.9% | 0.34% | +17.0% |
| Q1 2020 | $1,983,000 | -43.0% | 24,523 | -41.0% | 0.29% | -17.5% |
| Q4 2019 | $3,476,000 | -6.2% | 41,583 | -2.1% | 0.35% | -14.5% |
| Q3 2019 | $3,707,000 | -14.1% | 42,477 | -19.5% | 0.41% | -25.4% |
| Q2 2019 | $4,316,000 | +2.1% | 52,738 | +1.2% | 0.55% | -4.9% |
| Q1 2019 | $4,229,000 | +21.2% | 52,088 | -1.6% | 0.58% | +4.9% |
| Q4 2018 | $3,489,000 | -16.0% | 52,958 | -1.7% | 0.55% | +8.1% |
| Q3 2018 | $4,154,000 | +4.6% | 53,891 | +0.3% | 0.51% | -5.2% |
| Q2 2018 | $3,973,000 | +8.2% | 53,731 | -4.8% | 0.54% | +10.3% |
| Q1 2018 | $3,672,000 | +0.6% | 56,456 | -0.1% | 0.48% | +0.4% |
| Q4 2017 | $3,649,000 | -2.7% | 56,531 | -5.2% | 0.48% | -10.9% |
| Q3 2017 | $3,750,000 | +4.5% | 59,656 | +0.5% | 0.54% | -9.1% |
| Q2 2017 | $3,587,000 | +6.9% | 59,381 | -8.2% | 0.60% | +5.3% |
| Q1 2017 | $3,356,000 | +14.7% | 64,691 | -2.2% | 0.57% | +17.4% |
| Q4 2016 | $2,926,000 | -9.1% | 66,123 | -1.9% | 0.48% | -10.4% |
| Q3 2016 | $3,219,000 | +6.9% | 67,376 | +1.5% | 0.54% | +1.7% |
| Q2 2016 | $3,010,000 | +6.3% | 66,358 | -4.2% | 0.53% | +3.5% |
| Q1 2016 | $2,832,000 | +7.5% | 69,255 | +0.4% | 0.51% | +6.0% |
| Q4 2015 | $2,635,000 | +14.6% | 69,005 | -1.5% | 0.48% | +13.4% |
| Q3 2015 | $2,299,000 | -53.4% | 70,069 | -0.8% | 0.42% | -46.9% |
| Q2 2015 | $4,929,000 | -5.4% | 70,599 | -7.0% | 0.80% | -7.8% |
| Q1 2015 | $5,209,000 | -4.1% | 75,935 | +2.4% | 0.87% | -5.5% |
| Q4 2014 | $5,429,000 | +4.4% | 74,162 | +2.4% | 0.92% | +4.0% |
| Q3 2014 | $5,201,000 | -0.2% | 72,431 | +0.2% | 0.88% | +0.7% |
| Q2 2014 | $5,212,000 | +56.7% | 72,290 | +59.9% | 0.88% | +4.4% |
| Q1 2014 | $3,327,000 | – | 45,209 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |